KCNJ14 Knockdown Significantly Inhibited the Proliferation and Migration of Colorectal Cells

Overview

Journal BMC Med Genomics

Publisher Biomed Central

Specialty Genetics

Date 2022 Sep 13

PMID 36100894

Authors

Bin Li

Ning Ge

Zhongping Pan

Chaofeng Hou

Kun Xie

Dongfang Wang

Junwei Liu

Jie Wan

Feihong Deng

Mengyi Li

Shuping Luo

Affiliations

Soon will be listed here.

Abstract

Background: This study attempted to verify the potential of KCNJ14 as a biomarker in colorectal cancer (CRC).

Methods: Data on transcriptomics and DNA methylation and the clinical information of CRC patients were downloaded from The Cancer Genome Atlas and Gene Expression Omnibus databases. Biological information analysis methods were conducted to determine the role of KCNJ14 in the prognosis, diagnosis, immune cell infiltration, and regulation mechanism of CRC patients. The effect of KCNJ14 on the proliferation and migration of HCT116 and SW480 CRC cell lines was verified by in vitro experiments (MTT, colony-forming, wound healing, and transwell assays). Western blotting was performed to detect the effect of KCNJ14 on the levels of mTOR signalling pathway-related proteins.

Results: KCNJ14 expression was remarkably increased in CRC tissues and cell lines, which reduced the overall survival time of patients. KCNJ14 mRNA was negatively regulated by its methylation site cg17660703, which can also endanger the prognosis of patients with CRC. Functional enrichment analysis suggested that KCNJ14 is involved in the mTOR, NOD-like receptor, and VEGF signalling pathways. KCNJ14 expression was positively correlated with the number of CD4 + T cells and negatively correlated with that of CD8 + T cells in the immune microenvironment. KCNJ14 knockdown significantly reduced not only the proliferation and migration of CRC cell lines but also the levels of mTOR signalling pathway-related proteins.

Conclusions: This study not only increases the molecular understanding of KCNJ14 but also provides a potentially valuable biological target for the treatment of colorectal cancer.

Citing Articles

Identification of cancer-associated fibroblast signature genes for prognostic prediction in colorectal cancer.

Jin W, Lu Y, Lu J, Wang Z, Yan Y, Liang B Front Genet. 2025; 16:1476092.

PMID: 40041860 PMC: 11876384. DOI: 10.3389/fgene.2025.1476092.

Comprehensive Analysis of KCNJ14 Potassium Channel as a Biomarker for Cancer Progression and Development.

Alasiri G Int J Mol Sci. 2023; 24(3).

PMID: 36768373 PMC: 9916715. DOI: 10.3390/ijms24032049.

References

Thuringer D, Chanteloup G, Boucher J, Pernet N, Boudesco C, Jego G . Modulation of the inwardly rectifying potassium channel Kir4.1 by the pro-invasive miR-5096 in glioblastoma cells. Oncotarget. 2017; 8(23):37681-37693. PMC: 5514940. DOI: 10.18632/oncotarget.16949. View

Liu Z, Shen F, Wang H, Li A, Wang J, Du L . Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients. Cell Cycle. 2020; 19(13):1632-1640. PMC: 7469623. DOI: 10.1080/15384101.2020.1762038. View

Pinho R, Maga E . DNA methylation as a regulator of intestinal gene expression. Br J Nutr. 2021; 126(11):1611-1625. DOI: 10.1017/S0007114521000556. View

Lee I, Lee S, Kang T, Kang W, Park C . Unconventional role of the inwardly rectifying potassium channel Kir2.2 as a constitutive activator of RelA in cancer. Cancer Res. 2012; 73(3):1056-62. DOI: 10.1158/0008-5472.CAN-12-2498. View

Liu S, Fan W, Gao X, Huang K, Ding C, Ma G . Estrogen receptor alpha regulates the Wnt/β-catenin signaling pathway in colon cancer by targeting the NOD-like receptors. Cell Signal. 2019; 61:86-92. DOI: 10.1016/j.cellsig.2019.05.009. View

Thorsteinsson M, Kirkeby L, Hansen R, Lund L, Sorensen L, Gerds T . Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature. Int J Colorectal Dis. 2012; 27(12):1579-86. DOI: 10.1007/s00384-012-1517-4. View

Hu W, Sun R, Chen L, Zheng X, Jiang J . Prognostic significance of resident CD103CD8T cells in human colorectal cancer tissues. Acta Histochem. 2019; 121(5):657-663. DOI: 10.1016/j.acthis.2019.05.009. View

Kostic A, Chun E, Robertson L, Glickman J, Gallini C, Michaud M . Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013; 14(2):207-15. PMC: 3772512. DOI: 10.1016/j.chom.2013.07.007. View

Tinker A, Aziz Q, Li Y, Specterman M . ATP-Sensitive Potassium Channels and Their Physiological and Pathophysiological Roles. Compr Physiol. 2018; 8(4):1463-1511. DOI: 10.1002/cphy.c170048. View

10.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

11.

Lamb J, Crawford E, Peck D, Modell J, Blat I, Wrobel M . The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006; 313(5795):1929-35. DOI: 10.1126/science.1132939. View

12.

Liu H, Huang J, Peng J, Wu X, Zhang Y, Zhu W . Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway. Mol Cancer. 2015; 14:59. PMC: 4373128. DOI: 10.1186/s12943-015-0298-0. View

13.

Robertson K . DNA methylation and human disease. Nat Rev Genet. 2005; 6(8):597-610. DOI: 10.1038/nrg1655. View

14.

Toor S, Murshed K, Al-Dhaheri M, Khawar M, Nada M, Elkord E . Immune Checkpoints in Circulating and Tumor-Infiltrating CD4 T Cell Subsets in Colorectal Cancer Patients. Front Immunol. 2020; 10:2936. PMC: 6928042. DOI: 10.3389/fimmu.2019.02936. View

15.

Ye X, Sun Y, Xu Y, Chen Z, Lu S . Integrated In Silico-In Vitro Discovery of Lung Cancer-related Tumor Pyruvate Kinase M2 (PKM2) Inhibitors. Med Chem. 2016; 12(7):613-620. DOI: 10.2174/1573406412666160307151535. View

16.

Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M . Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. DOI: 10.1016/S0140-6736(19)32319-0. View

17.

Jjingo D, Conley A, Yi S, Lunyak V, Jordan I . On the presence and role of human gene-body DNA methylation. Oncotarget. 2012; 3(4):462-74. PMC: 3380580. DOI: 10.18632/oncotarget.497. View

18.

Bryan S, Masoud H, Weir H, Woods R, Lockwood G, Smith L . Cancer in Canada: Stage at diagnosis. Health Rep. 2018; 29(12):21-25. View

19.

Yang J, Qi M, Fei X, Wang X, Wang K . LncRNA H19: A novel oncogene in multiple cancers. Int J Biol Sci. 2021; 17(12):3188-3208. PMC: 8375239. DOI: 10.7150/ijbs.62573. View

20.

Irizarry R, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P . The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009; 41(2):178-186. PMC: 2729128. DOI: 10.1038/ng.298. View